PRevEnting FracturEs in REnal Disease - 1

NCT05096195 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Kidney Diseases
Dialysis; Complications
Fragility Fracture
Chronic Kidney Disease-Mineral and Bone Disorder

Interventions

DRUG: Denosumab 60 mg/ml
OTHER: Calcium and vitamin D prophylaxis
DIAGNOSTIC_TEST: Monitoring of post-injection calcium and phosphate

Sponsor

Western University, Canada

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]